These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. Simor AE. J Am Geriatr Soc; 2010 Aug; 58(8):1556-64. PubMed ID: 20646106 [Abstract] [Full Text] [Related]
3. Clostridium difficile infection is a treatable cause of diarrhea in patients with advanced human immunodeficiency virus infection: a study of seven consecutive patients admitted from 1986 to 1992 to a university teaching hospital. Cappell MS, Philogene C. Am J Gastroenterol; 1993 Jun; 88(6):891-7. PubMed ID: 8503386 [Abstract] [Full Text] [Related]
10. The diagnosis and treatment of Clostridium difficile in antibiotic-associated diarrhea. Gorenek L, Dizer U, Besirbellioglu B, Eyigun CP, Hacibektasoglu A, Van Thiel DH. Hepatogastroenterology; 1999 May; 46(25):343-8. PubMed ID: 10228818 [Abstract] [Full Text] [Related]
12. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins. Pituch H, Obuch-Woszczatyński P, Wultańska D, van Belkum A, Meisel-Mikołajczyk F, Łuczak M. Diagn Microbiol Infect Dis; 2007 May; 58(1):71-5. PubMed ID: 17300901 [Abstract] [Full Text] [Related]
13. [Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections]. Barbut F, Petit JC. Pathol Biol (Paris); 2000 Oct; 48(8):745-55. PubMed ID: 11244603 [Abstract] [Full Text] [Related]
18. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents. Nomura K, Fujimoto Y, Yamashita M, Morimoto Y, Ohshiro M, Sato K, Oyake T, Kowata S, Konishi H, Yoshikawa T, Ishida Y, Taniwaki M, Japan Hematology/Oncology Study (J-HOST) Group Kyoto. Scand J Gastroenterol; 2009 Nov 04; 44(1):74-8. PubMed ID: 18781540 [Abstract] [Full Text] [Related]